StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
Huagongshe Open Project:[email protected]KI-Anbindung: llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.7.8
Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 6464Erstellt: 4. November 2026

Aprobarbital

Numal · Isonal · Aprozal · Allonal · Alurate · Allional · NSC120769 · Aprobarbita

https://huagongshe.com/de/chemical/6464

Molekülstruktur von Aprobarbital

Identifikatoren & physikalische Daten

CAS No.77-02-1
SummenformelC10H14N2O3
Durchschnittliche Molmasse210,23 g/mol
Monoisotopische Masse210,10044231 g/mol
SMILESC=CCC1(C(C)C)C(=O)NC(=O)NC1=O
InChIKeyUORJNBVJVRLXMQ-UHFFFAOYSA-N
PubChem CID6464
ChEMBLCHEMBL7863
ChEBICHEBI:2791
EC No.200-997-4
DTXSIDDTXSID8022616
Lokaler NameAprobarbital

Chemische & physikalische Eigenschaften

XLogP1,1
Polarare Oberfläche (TPSA)75,3
H-Brücken-Donoren2
H-Brücken-Akzeptoren3
Frei drehbare Bindungen3
Schwere Atome15
Formalladung0
Komplexität314
ArzneimittelDEA NFLIS-Drug Category -> Depressants and TranquilizersPharmaceuticals -> BarbituratesPharmaceuticals -> Listed in ZINC15
pHA SATURATED AQUEOUS SOLN IS ACID TO LITMUS
SpringerMaterials PropertiesDensity
LogP (Verteilungskoeffizient)1.151.22
GeschmackSLIGHTLY BITTER
Color/FormCRYSTALSFine, white, crystalline powder
LöslichkeitPOWDERHYGROSCOPICSLIGHTLY BITTER TASTEVERY SOL IN WATERSLIGHTLY SOL IN ALCPRACTICALLY INSOL IN ETHERAQ SOLN ARE ALKALINE TO LITMUS /APROBARBITAL SODIUM SALT/ALMOST INSOL IN WATER, PETROLEUM ETHER, ALIPHATIC HYDROCARBONSSOL IN ALC, CHLOROFORM, ETHER, ACETONE, BENZENE, GLACIAL ACETIC ACID, FIXED ALKALI HYDROXIDE SOLN.Lipid solubility is low.5.17e+00 g/LDMSO (Slightly), Methanol (Slightly)4.121g/L(25 ºC)
DecompositionWhen heated to decomp it emits toxic fumes of oxides of nitrogen. /Aprobarbital sodium/
Schmelzpunkt140-141.5 °C141 °C140-141.5°
BrechungsindexINDEX OF REFRACTION ALPHA: 1.520BETA: 1.581GAMMA: 1.6001.5000 (estimate)
Physical DescriptionSolid
Stability/Shelf LifeSTABLE IN AIR
Siedepunkt349.75°C (rough estimate)
Dichte1.2056 (rough estimate)
Lagerbedingungen2-8°C
pKa (Säurekonstante)7.81±0.10(Predicted)
AggregatzustandSolid
FarbeWhite to Off-White
Hauptanwendungenforensics and toxicology
InChI1S/C10H14N2O3/c1-4-5-10(6(2)3)7(13)11-9(15)12-8(10)14/h4,6H,1,5H2,2-3H3,(H2,11,12,13,14,15)
InChIKeyUORJNBVJVRLXMQ-UHFFFAOYSA-N
SMILESO=C1C(C(C)C)(CC=C)C(NC(N1)=O)=O

Sicherheit & Vorschriften

GHS-EinstufungDangerH301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 40 reports by companies from 1 notifications to the ECHA C&L Inventory.
Weitere SicherheitsinformationenIMAP assessments - 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylethyl)-5-(2-propenyl)-: Human health tier I assessment
FDA-AnforderungenManufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended21 U.S.C. 321-392).5-Allyl-5-isopropylbarbituric acid is a chemical derivative of barbituric acid, named in section 502(d) of the Federal Food, Drug, and Cosmetic Act, and is hereby designated as habit forming.Warning and caution statements for 5-allyl-5-isopropylbarbituric acid specifically required by law. PREPARATIONS CONTAINING HABIT-FORMING DERIVATIVES OF SUBSTANCES NAMED IN SECTION 502(d) OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT ... The statement "Warning-May be habit forming" is required to appear on the labels of all drugs containing derivatives designated in 21 CFR 329.1 ... as habit forming.Schedules of controlled substances are established by section 202 of the Controlled Substances Act (21 U.S.C. 812). Schedule III includes any substance which contains any quantity of a derivative of barbituric acid or any salt thereof. DEA Code #2100Drug class: Depressant. /Derivatives of barbituric acid or any salt thereof/For more FDA Requirements (Complete) data for APROBARBITAL (6 total), please visit the HSDB record page.
Hazard Classes and CategoriesAcute Tox. 3 (100%)
LagerbedingungenOral solution should be stored in tight, light-resistant containers at a temperature less than 40 °C, preferably between 15 to 30 °Cfreezing should be avoided. ... Expiration date /is/ 4 years following the date of manufacture.
WechselwirkungenIN CAT CEREBRAL CORTEX, BARBITURATES IN ANESTHETIC DOSES SELECTIVELY ABOLISH EXCITATION BUT NOT INHIBITION ELICITED BY NOREPINEPHRINE APPLIED DIRECTLY TO VARIOUS SYNAPSES... /BARBITURATES/

Anwendungen & Verwendung

Verwenden

Controlled substance (depressant). Sedative, hypnotic.

AT SKELETAL NEUROMUSCULAR JUNCTIONS BLOCKING EFFECTS OF BOTH D-TUBOCURARINE & DECAMETHONIUM ARE ENHANCED BY BARBITURATES. /BARBITURATES/
BOTH CARDIAC GLYCOSIDES & BETA-ADRENERGIC AGONISTS ANTAGONIZE MYOCARDIAL DEPRESSANT ACTION /OF BARBITURATES/. /BARBITURATES/
INTENSITY OF CNS DEPRESSION CAN BE INCR BY ACIDIC DRUGS SUCH AS ASPIRIN ... WHICH DISPLACE BARBITURATES FROM PLASMA PROTEINS. /BARBITURATES/
For more Interactions (Complete) data for APROBARBITAL (14 total), please visit the HSDB record page.
Human Toxicity Excerpts... BARBITURATES REDUCE AMT OF TIME SPENT IN REM PHASE SLEEP, &, IN THIS ... BARBITURATE-INDUCED SLEEP DIFFERS FROM PHYSIOLOGICAL SLEEP. ... CLAIMED ... THAT DEPRIVATION OF THIS PHASE ... MAY HAVE DELETERIOUS EFFECTS. SUBJECTS DEPRIVED OF REM ... EXHIBIT REBOUND INCR IN ... TIME SPENT IN REM SLEEP FOLLOWING ... DEPRIVATION. /BARBITURATE/PROLONGED USE OF BARBITURATES INCR RESTLESSNESS DURING LATE STAGES OF SLEEP, CAUSES ANXIETY, & INCR PLASMA CONCN OF GROWTH HORMONE BUT DECR THOSE OF ADRENOCORTICOIDS. ... IN SMALL DOSES, BARBITURATES MAY INCR REACTION TO PAINFUL STIMULI. /BARBITURATES/OXYBARBITURATES TEND TO DECR TONUS OF GI MUSCULATURE & AMPLITUDE OF RHYTHMIC CONTRACTIONS. /OXYBARBITURATES/SEVERE OLIGURIA OR ANURIA MAY OCCUR IN ACUTE ... POISONING, LARGELY AS RESULT OF MARKED HYPOTENSION. /BARBITURATES/For more Human Toxicity Excerpts (Complete) data for APROBARBITAL (17 total), please visit the HSDB record page.
Antidote and Emergency TreatmentTREATMENT: Stabilization: Respiratory arrest is the major cause of early death. Assess the patency of the airway and the adequacy of ventilation first. Appropriate corrective measures include supplemental oxygen, head tilt-chin lift, intubation, and assisted ventilation. Establish an iv line with Ringer's lactate and give a fluid challenge up to 2 l for patients who are hypotensive. Cardiac dysrhythmias are rare but were reported. ... Be sure to give glucose, naloxone, and thiamine to all patients with depressed mental status. /Barbiturates/Gut Decontamination: Because of decr gastrointestinal mobility and delayed gastric emptying, gut decontamination is indicated 6-8 hr postingestion in obtunded patients. Barbiturates are well absorbed by charcoal10 times the ingested dose (or 1 g/kg body weight) should be given together with a cathartic (sorbitol, magnesium citrate) to all patients. /Barbiturates/Elimination Enhancement: Most overdose patients respond to supportive care and require no special measures. ... Alkaline diuresis is ineffective for short and intermediate acting barbiturates. ... Hemoperfusion: This measure is more effective than dialysis for short and intermediate acting barbiturates. ...Antidotes: No effective antidotes are available. Respiratory and central nervous stimulants incr complications and should be avoided. /Barbiturates/
Wassergefährdungsklasse (WGK)WGK 2
R-Sätze (R)11-23/25-36/38
ToxizitätLD50 i.p. in mice: 200 mg/kg (Frey)
GefahrensymboleF,T
Sicherheitshinweise (S)16-24-45
Lagerklasse3 - Flammable liquids
Gefahrstoffdaten77-02-1(Hazardous Substances Data)
GefahrenklasseAcute Tox. 3 DermalAcute Tox. 3 InhalationAcute Tox. 3 OralFlam. Liq. 2STOT SE 1
DEA Controlled SubstancesCSCN: 2100CSA SCH: Schedule IIINARC: No